Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-12, Stock:ABBV, The news for the past five days is as follows:
2019-07-05: NEWS1: Top Stock Reports for Amazon, UnitedHealth & AbbVie.NEWS2: AbbVie Falls 3%.
2019-07-08: NEWS1: 3 Dividend Stocks Retirees Must Have in Their Portfolios.NEWS2: ObsEva Ends Recruitment in Second Uterine Fibroids Study.NEWS3: The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk.NEWS4: The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk.NEWS5: AbbVie (ABBV) Shares Down So Far This Year: Here's Why.NEWS6: AbbVie (ABBV) Shares Down So Far This Year: Here's Why.NEWS7: Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice.NEWS8: Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice.NEWS9: The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk.NEWS10: AbbVie (ABBV) Shares Down So Far This Year: Here's Why.NEWS11: Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice.
2019-07-09: NEWS1: The S&P 500’s 5 Best Highest-Yielding Dividend Stocks.NEWS2: The S&P 500’s 5 Best Highest-Yielding Dividend Stocks.NEWS3: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS4: The S&P 500’s 5 Best Highest-Yielding Dividend Stocks.NEWS5: ObsEva Ends Recruitment in Second Uterine Fibroids Study.NEWS6: ObsEva Ends Recruitment in Second Uterine Fibroids Study.
2019-07-10: NEWS1: Analyst: CytomX Therapeutics Validated By AbbVie Decision.NEWS2: Ex-Dividend Reminder: Becton, Dickinson, Abbott Laboratories and AbbVie.NEWS3: Ex-Dividend Reminder: Becton, Dickinson, Abbott Laboratories and AbbVie.NEWS4: Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019.NEWS5: Will Patent Woes Boost Pharma Stock Megamergers Further?.NEWS6: AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue.
2019-07-11: NEWS1: FDA Accepts Neurocrine's NDA for Parkinson's Disease Drug.NEWS2: FDA Accepts Neurocrine's NDA for Parkinson's Disease Drug.NEWS3: ITOT, ABBV, GE, AXP: Large Outflows Detected at ETF.NEWS4: ITOT, ABBV, GE, AXP: Large Outflows Detected at ETF.NEWS5: FDA Accepts Neurocrine's NDA for Parkinson's Disease Drug.NEWS6: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS7: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS8: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS9: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019.NEWS10: AbbVie to Host Second-Quarter 2019 Earnings Conference Call.NEWS11: J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?.NEWS12: 2 Falling Pharma Stocks Whose Star May Rise in 2019.

Answer: Decrease